Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$163,506,307
+$39,843,234 QoQ
Shares Held
136,320
+1.4% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#294
of 4,621 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$2,878,632
CallShares
2,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vontobel Holding Ltd. holds $908,993,306 across 12 Drug Manufacturers - General names. LLY ranks #2 (18.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,300,930 | $330,397,188 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
136,320 | $163,506,307 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
947,749 | $119,738,606 | |
| 4 | AZN |
Astrazeneca PLC
|
346,381 | $65,680,764 | |
| 5 | AMGN |
Amgen Inc
|
155,115 | $56,170,241 | |
| 6 | ABBV |
AbbVie Inc.
|
198,110 | $49,852,399 | |
| 7 | MRK |
Merck & Co., Inc.
|
385,052 | $49,479,181 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
725,587 | $41,808,321 |
All Filings in LLY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $163,506,307 | 136,320 | Shares | Defined | 2026-08-03 | |
| 2026-06-30 | $2,878,632 | 2,400 | Call | Defined | 2026-08-03 | |
| 2026-03-31 | $123,663,073 | 134,450 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $3,761,380 | 3,500 | Call | Defined | 2026-02-13 | |
| 2025-12-31 | $115,890,276 | 107,837 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $83,949,838 | 110,026 | Shares | Defined | 2025-10-15 | |
| 2025-09-30 | $381,500 | 500 | Call | Defined | 2025-10-15 | |
| 2025-06-30 | $3,585,838 | 4,600 | Call | Defined | 2025-07-23 | |
| 2025-06-30 | $80,738,258 | 103,573 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $78,396,201 | 94,921 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $73,669,644 | 95,427 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $76,344,990 | 86,174 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $95,504,006 | 105,485 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $97,380,363 | 125,174 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $67,369,811 | 115,573 | Shares | Defined | 2024-06-04 | |
| 2023-09-30 | $62,853,339 | 117,017 | Shares | Defined | 2024-06-04 | |
| 2023-06-30 | $60,019,120 | 127,978 | Shares | Defined | 2024-06-04 | |
| 2023-03-31 | $49,226,852 | 143,343 | Shares | Defined | 2024-06-04 | |
| 2022-12-31 | $46,329,610 | 126,639 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $41,386,211 | 127,992 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $33,253,351 | 102,561 | Shares | Defined | 2022-07-27 | |
| 2022-03-31 | $25,852,049 | 90,275 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,767,013 | 100,525 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,075,780 | 65,249 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $14,711,083 | 64,095 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $13,773,303 | 73,725 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $12,984,470 | 76,904 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||